Cargando…
Efficacy of sorafenib, a multi-tyrosine kinase inhibitor, in an adenoid cystic carcinoma metastatic to the lung: case report and review of literature
INTRODUCTION: Treatment for squamous cell carcinoma of the head and neck has significantly improved with the addition of cetuximab, a monoclonal antibody against the epidermal growth factor receptor, to conventional cytotoxic agents. The most significant aspect of this treatment approach is the proo...
Autores principales: | Dammrich, Daniel J, Santos, Edgardo S, Raez, Luis E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191347/ https://www.ncbi.nlm.nih.gov/pubmed/21951623 http://dx.doi.org/10.1186/1752-1947-5-483 |
Ejemplares similares
-
Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer
por: Cerquetti, Lidia, et al.
Publicado: (2021) -
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma
por: Lee, Rex H., et al.
Publicado: (2022) -
Efficacy and safety of anlotinib in metastatic adenoid cystic carcinoma: a retrospective study
por: Su, Ning, et al.
Publicado: (2022) -
Metastatic Intracranial Adenoid Cystic Carcinoma with Unknown Primary: Case Report and Review of Literature
por: Chaturvedi, Jitender, et al.
Publicado: (2017) -
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
por: Gotink, Kristy J., et al.
Publicado: (2015)